Transfer of Methamphetamine (MA) into Breast Milk and Urine of Postpartum Women who Smoked MA Tablets during Pregnancy

Abstract

Background:

Methamphetamine (MA) use by pregnant women remains a growing problem in South East Asia. After delivery, a negative maternal urine MA assay is assumed to reflect the absence of MA in breast milk and marks breastfeeding initiation. To date, no data exist that describe the relationship between the peripartum and postpartum transfer of MA into breast milk and its urinary excretion in women, following recreational use by smoking.

Objective:

This study aimed to determine the pharmacokinetic of smoked MA in breast milk and its relationship to urinary MA excretion in postpartum women who tested positive for MA before delivery.

Methods:

Timed urine and breast milk samples of 33 women who had positive urine drug screens for MA prior to delivery were analyzed for MA using Acquity Ultra Performance Liquid Chromatography (Waters, Milford, Massachusetts, USA) with the ACQUITY UPLC Photodiode Array Detector (Waters). Those participants with 4 or more timed breast milk samples were included for pharmacokinetic calculation using log-linear trapezoidal rule.

Results:

Pharmacokinetic data from 2 women were analyzed. The half-life values for MA in the breast milk were 11.3 and 40.3 hours. The absolute infant doses were 21.3 and 51.7 µg/kg/day. Methamphetamine disappears from breast milk approximately 1 day before the maternal urine MA becomes negative.

Conclusion:

Smoked MA shows a similar breast milk pharmacokinetic pattern to previously reported intravenous MA. Breastfeeding can be safely initiated in mothers whose urine MA screen has turned negative for ≥ 24 hours. However, concurrent maternal substance use treatment and screening is necessary for continued promotion of lactation.

Keywords

amphetamine-type stimulant ATS breastfeeding breast milk drugs of abuse methamphetamine pregnancy

Get full access to this article

View all access options for this article.

References

UNODC. World drug report 2014. http://www.unodc.org/southasia//frontpage/2014/Jan/india-first-ever-study-looks-at-trends-in-amphetamine-type-stimulants-use.html. Published 2014. Accessed December 23, 2014.

Dargan

Wood

. Recreational drug use in the Asia Pacific region: improvement in our understanding of the problem through the UNODC programmes. J Med Toxicol. 2012;8(3):295-299.

UNODC. Regional overview. In: UNODC, ed. World Drug Report 2011. Vienna: United Nations; 2011:35-45.

UNODC. The market for amphetamine-type stimulants. In: UNODC, ed. World Drug Report 2013. Vienna: United Nations; 2013:49-58.

Vearrier

Greenberg

Miller

Okaneku

Haggerty

. Methamphetamine: history, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine. Dis Mon. 2012;58(2):38-89.

Chomchai

Manaboriboon

. Stimulant methamphetamine and dextromethorphan use among Thai adolescents: implications for health of women and children. J Med Toxicol. 2012;8(3):291-294.

Courtney

Ray

. Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature. Drug Alcohol Depend. 2014;143:11-21.

Whiteford

Degenhardt

Rehm

. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2014;382(9904):1575-1586.

Chomchai

Na Manorom

Watanarungsan

. Methamphetamine abuse during pregnancy and its health impact on neonates born at Siriraj Hospital, Bangkok, Thailand. Southeast Asian J Trop Med Public Health. 2004;35(1):228-231.

10.

Zapata

Hillis

Marchbanks

Curtis

Lowry

. Methamphetamine use is independently associated with recent risky sexual behaviors and adolescent pregnancy. J Sch Health. 2008;78(12):641-648.

11.

Chomchai

. Global patterns of methamphetamine use. Curr Opin Psychiatry. 2015;28(4):269-274.

12.

Cruickshank

Dyer

. A review of the clinical pharmacology of methamphetamine. Addiction. 2009;104(7):1085-1099.

13.

Cook

Jeffcoat

Hill

. Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride. Drug Metab Dispos. 1993;21(4):717-723.

14.

Verstraete

Heyden

. Comparison of the sensitivity and specificity of six immunoassays for the detection of amphetamines in urine. J Anal Toxicol. 2005;29(5):359-364.

15.

American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics. 2001;108(3):776-789.

16.

Ramamoorthy

Leibach

Ganapathy

. Human placental monoamine transporters as targets for amphetamines. Am J Obstet Gynecol. 1995;173(6):1782-1787.

17.

Ilett

Hackett

Kristensen

Kohan

. Transfer of dexamphetamine into breast milk during treatment for attention deficit hyperactivity disorder. Br J Clin Pharmacol. 2007;63(3):371-375.

18.

Steiner

Villén

Hallberg

Rane

. Amphetamine secretion in breast milk. Eur J Clin Pharmacol. 1984;27(1):123-124.

19.

Gorman

Orme

Nguyen

Kent

III Caughey

. Outcomes in pregnancies complicated by methamphetamine use. Am J Obstet Gynecol. 2014;211(4):429.e1-429.e7.

20.

Good

Solt

Acuna

Rotmensch

Kim

. Methamphetamine use during pregnancy: maternal and neonatal implications. Obstet Gynecol. 2010;116(2, pt 1):330-334.

21.

Little

Snell

Gilstrap

III Johnston

. Patterns of multiple substance abuse during pregnancy: implications for mother and fetus. South Med J. 1990;83(5):507-509, 518.

22.

Plessinger

. Prenatal exposure to amphetamines. Risks and adverse outcomes in pregnancy. Obstet Gynecol Clin North Am. 1998;25(1):119-138.

23.

Stewart

Meeker

. Fetal and infant deaths associated with maternal methamphetamine abuse. J Anal Toxicol. 1997;21(6):515-517.

24.

Madide

Smith

Odendaal

. Methamphetamine use by pregnant women: impact on the neonate and challenges for the perinatal team. Obstetrics and Gynaecology Forum. 2012;22(1):8-11.

25.

Shah

Diaz

Arria

. Prenatal methamphetamine exposure and short-term maternal and infant medical outcomes. Am J Perinatol. 2012;29(5):391-400.

26.

Oei

Kingsbury

Dhawan

. Amphetamines, the pregnant woman and her children: a review. J Perinatol. 2012;32(10):737-747.

27.

Marchei

Escuder

Pallas

. Simultaneous analysis of frequently used licit and illicit psychoactive drugs in breast milk by liquid chromatography tandem mass spectrometry. J Pharm Biomed Anal. 2011;55(2):309-316.

28.

Fatemi

Ghorbanzad’e

. Classification of drugs according to their milk/plasma concentration ratio. Eur J Med Chem. 2010;45(11):5051-5055.

29.

Bartu

Dusci

Ilett

. Transfer of methylamphetamine and amphetamine into breast milk following recreational use of methylamphetamine. Br J Clin Pharmacol. 2009;67(4):455-459.

30.

Öhman

Wikner

Beck

Sarman

. Narcolepsy treated with racemic amphetamine during pregnancy and breastfeeding. J Hum Lact. 2015;31(3):374-376.

31.

Green

. People v Henderson: the prosecution responds. JAMA. 1996;275(3):183-183.

32.

Ariagno

Karch

Middleberg

Stephens

Valdès-Dapena

. Methamphetamine ingestion by a breast-feeding mother and her infant’s death: People v Henderson. JAMA. 1995;274(3):215-215.

33.

Chomchai

In-iew

. Thai comprehensive care of methamphetamine exposed teenage mother and child [in Thai]. Paper presented at: Healthy Society Beyong Frontier 2013; 2013; Siriraj Hospital, Bangkok, Thailand.

34.

Jaques

Kingsbury

Henshcke

. Cannabis, the pregnant woman and her child: weeding out the myths. J Perinatol. 2014;34(6):417-424.

35.

American College of Obstetricians and Gynecologists Committee on Health Care for Underserved Women. Committee opinion no. 479: methamphetamine abuse in women of reproductive age. Obstet Gynecol. 2011;117(3):751-755.

36.

Wong

Ordean

Kahan

. SOGC clinical practice guidelines: substance use in pregnancy: no. 256, April 2011. Int J Gynaecol Obstet. 2011;114(2):190-202.

37.

Sachs

, Committee On Drugs. The transfer of drugs and therapeutics into human breast milk: an update on selected topics. Pediatrics. 2013;132(3):e796-e809.

38.

Hongfa

Boonprasert

. The effect of biological matrices on the reliability of methamphetamine analysis. Mj Int J Sci Tech. In press.

39.

Greenfeld

. The need for speed. Time (Asian ed). March 4, 2001.

40.

Drug excretion in breast milk: mechanisms, models and drug delivery implications for the infant. Adv Drug Deliv Rev. 2003;55(5):615-616.

41.

Berlin

Briggs

. Drugs and chemicals in human milk. Semin Fetal Neonatal Med. 2005;10(2):149-159.

42.

Fleishaker

. Models and methods for predicting drug transfer into human milk. Adv Drug Deliv Rev. 2003;55(5):643-652.

43.

Ito

Lee

. Drug excretion into breast milk—overview. Adv Drug Deliv Rev. 2003;55(5):617-627.

44.

McNamara

Abbassi

. Neonatal exposure to drugs in breast milk. Pharm Res. 2004;21(4):555-566.